References
- Amanda J. Berberich, Robert A. Hegele. The role of genetic testing in dyslipidaemia. Science Direct, Volume 51, Issue 2, February 2019, Pages 184–192
- Raymond Henderson, Maurice O’Kane, Victoria McGilligan, Steven Watterson. The genetics and screening of familial hypercholesterolaemia. J Biomed Sci. Apr 16, 2016
- Luke Hamilton, MS, Ariel Brautbar, MD, and Don P. Wilson, MD. Principles of Genetic Testing for Dyslipidemia in Children. Endotext, January 23, 2021
- Andrews LB. Assessing Genetic Risks: Implications for Health and Social Policy. Institute of Medicine (US) Committee on Assessing Genetic Risks, Washington (DC): National Academies Press (US); 1994; Chapter 2 - Genetic Testing and Assessment
- Andrews LB. Assessing Genetic Risks: Implications for Health and Social Policy. Institute of Medicine (US) Committee on Assessing Genetic Risks, Washington (DC): National Academies Press (US); 1994; Chapter 8 - Social, Legal, and Ethical Implications of Genetic Testing
- M Umans-Eckenhausen, F Oort, K Ferenschild, J Defesche, J Kastelein, J C J M de Haes. Parental attitude towards genetic testing for familial hypercholesterolaemia in children. J Med Genet. 2002 Sep; 39(9): e49
- Nina Hallowell, Nicholas Jenkins, Margaret Douglas, Simon Walker, Robert Finnie, Mary Porteous, Julia Lawton. A qualitative study of patients’ perceptions of the value of molecular diagnosis for familial hypercholesterolemia (FH). J Community Genet. 2017 Jan; 8(1): 45–52
- Karen Forrest Keenan, Robert M Finnie, William G Simpson, Lorna McKee, John Dean, Zosia Miedzybrodzka. Parents’ views of genetic testing and treatment of familial hypercholesterolemia in children: a qualitative study. J Community Genet. 2019 Jan;10(1):129–141
- Department of Health and Human Services. “GINA” The Genetic Information Nondiscrimination Act of 2008 Information for Researchers and Health Care Professionals April 6, 2009